Skip to main content
Livermore
Livermore
ZHEN

Amalgamated Bank

SEC CIK
0000919192
Latest filing
Jul 23, 2026

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by Amalgamated Bank, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overviewAll 13F holders of RAREFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of RARE by Amalgamated Bank, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−7,551−100.0%Sold outHolders
Q4 20257,551$174.0K<0.1%+325+4.5%AddedHolders
Q3 20257,226$217.0K<0.1%+469+6.9%AddedHolders
Q2 20256,757$246.0K<0.1%+598+9.7%AddedHolders
Q1 20256,159$223.0K<0.1%+187+3.1%AddedHolders
Q4 20245,972$251.0K<0.1%+76+1.3%AddedHolders
Q3 20245,896$328.0K<0.1%00.0%UnchangedHolders
Q2 20245,896$242.0K<0.1%+696+13.4%AddedHolders
Q1 20245,200$243.0K<0.1%−10,516−66.9%ReducedHolders
Q4 202315,716$752.0K<0.1%+1,427+10.0%AddedHolders
Q3 202314,289$509.0K<0.1%−398−2.7%ReducedHolders
Q2 202314,687$678.0K<0.1%+1,350+10.1%AddedHolders
Q1 202313,337$535.0K<0.1%−1,336−9.1%ReducedHolders
Q4 202214,673$680.0K<0.1%+251+1.7%AddedHolders
Q3 202214,422$597.0K<0.1%+134+0.9%AddedHolders
Q2 202214,288$852.0K<0.1%+117+0.8%AddedHolders
Q1 202214,171$1.03M<0.1%+968+7.3%AddedHolders
Q4 202113,203$1.11M<0.1%+1,524+13.0%AddedHolders
Q3 202111,679$1.05M<0.1%−688−5.6%ReducedHolders
Q2 202112,367$1.18M<0.1%+3,318+36.7%AddedHolders
Q1 20219,049$1.03M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.